180 Wealth Advisors’s CalciMedica CALC Stock Holding History

180 Wealth Advisors’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.9K	Sell	16,680 -8,620	-34%	-$30.6K	0.01%	478
2026 Q1	$68.3K	Buy	25,300 +18,930	+297%	+$192K	0.01%	467
2025 Q4	$210K	Sell	6,370 -2,170	-25%	-$42.3K	0.02%	440
2025 Q3	$131K	Sell	8,540 -1,550	-15%	-$22.3K	0.02%	441
2025 Q2	$80.7K	Buy	10,090 +6,810	+208%	+$58.5K	0.01%	416
2025 Q1	$31.3K	Buy	+3,280	New	+$40.9K	0.01%	410

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

180 Wealth Advisors's CALC Position: Q2 2026 in Review

180 Wealth Advisors reduced its CalciMedica (CALC) stake by 34% in Q2 2026, selling an estimated $30.6K and leaving 16,680 shares worth $85.9K. The position accounts for 0.01% of the portfolio, ranked #478.

180 Wealth Advisors first reported a position in CALC in Q1 2025 and has held it in 6 quarters since. The position peaked at $210K in Q4 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

180 Wealth Advisors held 16,680 shares of CalciMedica worth $85.9K as of Q2 2026.
180 Wealth Advisors sold 8,620 CalciMedica shares in Q2 2026, an estimated $30.6K.
CalciMedica made up 0.01% of 180 Wealth Advisors's portfolio in Q2 2026, its #478 holding.
180 Wealth Advisors first reported a position in CalciMedica in Q1 2025 and has held it in 6 quarters since.
180 Wealth Advisors's CalciMedica position peaked at $210K in Q4 2025.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.